Skip to content
Open access

Thymic age and peripheral residence time determine antitumor competence of CD8+ T cells.

Sep 2026 · Proceedings of the National Academy of Sciences of the United States of America · Vol 123 39, pp. e2612774123 · 0 citations · 25 references
Medicine

TL;DR

These findings establish developmental imprinting as an important determinant of CD8+ T cell heterogeneity and identify CXCR3+IL-18Rα+ CD8+ T cells as key effectors for antitumor immunity.

Abstract

The developmental timing of T cell generation imprints durable functional programs, yet how this shapes antitumor immunity remains unclear. Here, we combine genetic fate mapping with functional assays to dissect how thymic age and peripheral residency regulate CD8+ T cell behavior within the same host. We find that, compared with adulthood-derived CD8+ T cells, the adolescent-derived counterparts consistently exhibit enhanced tumor infiltration, increased effector cytokine production, and superior proliferative fitness. Transcriptomic and phenotypic profiling identify a CXCR3+IL-18Rα+ subset preferentially enriched among adolescent-derived T cells that shares core virtual memory-like features and displays elevated cytotoxic potential. Mechanistically, thymic origin timing and time spent in the periphery independently regulate the abundance and activity of this subset, revealing a two-tier control comprising developmental bias and postthymic remodeling. Functionally, CXCR3+IL-18Rα+ CD8+ T cells mediate potent tumor killing and confer robust therapeutic benefit in adoptive transfer models. Together, these findings establish developmental imprinting as an important determinant of CD8+ T cell heterogeneity and identify CXCR3+IL-18Rα+ CD8+ T cells as key effectors for antitumor immunity.

Read PDF

Similar papers

Review Open access Sep 2026

CD4+ cytotoxic T cells: context-dependent effectors in health and disease

Cytotoxic CD4 + T cells (CD4 + CTLs) have been identified as a specialized effector population characterized by potent cytotoxic machinery, including granzymes, perforin, and the Fas/FasL pathway, that enables the direct killing of MHC-II-expressing target cells. In addition to their classical helper function,...

Hao-Yang Yu, Jia-Xin Liang, Qi-Xuan Gu et al. · 0 citations
Review Open access Aug 2026

Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity

stem-like CD4 biology is presented as an emerging framework and established observations from working models are distinguished and established observations from working models are distinguished.

Jia-Xiang Xu, Yun-Chao Yang, Jun Zhang et al. · 0 citations
Open access Sep 2026

Subset-guided IL-15 expansion of NK cells amplifies antigen-specific CD4+ T cell immunity in melanoma

Natural killer (NK) cells comprise heterogeneous subsets with distinct developmental trajectories and effector functions; however, whether specific NK subsets can selectively coordinate adaptive antitumor immunity remains unclear. We identified a bone marrow-derived CD11c + B220 + NK subset (DPNKs) that is...

Chu-Yun Shen, Yu-Wei Chang, Li-Wen Tseng et al. · 0 citations
Open access Aug 2026

Functional heterogeneity and plasticity in naïve CD8 T cells drive superior effector and memory responses

While significant progress has been made in defining subsets among antigen-experienced CD8 T cells, the heterogeneity of naïve CD8 T cells remains poorly understood. Here, we identify naïve CD8 T cell subsets with superior persistence and an enhanced capacity to generate effector and memory cells, leading to more effec...

Yamato Sajiki, Satomi Ando, C. Perkins et al. · 0 citations
Open access Sep 2026

Neoantigen-reactive CD8+ T cell engagement marks exceptional survivors of pancreatic cancer

Pancreatic cancer (PC) is largely refractory to immune checkpoint blockade (ICB), although homologous recombination-deficient (HRD) tumors may derive benefit. In the POLAR trial of maintenance pembrolizumab plus olaparib after platinum-based chemotherapy for metastatic PC, responses remained heterogeneous. To define de...

M. Hilmi, J. Schoenfeld, Wilson H. McKerrow et al. · 0 citations
Open access Sep 2026

Single-cell mapping of thymus-dependent naïve t-cell regeneration reveals CD61-associated states after hematopoietic stem cell transplantation

Thymus-dependent de novo T-cell generation is essential for maintaining T-cell diversity and immune competence. Although thymic involution after puberty reduces thymic output, residual thymic function remains important for immune surveillance and immune reconstitution following hematopoietic stem cell transplantation (...

Fangqing Zhang, Xinya Jiang, Shuang Fan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.